NMN and NAD Supplements Fail to Deliver Anti-Aging Benefits in Human Studies

The promise of NAD precursor supplements for anti-aging has crumbled under scientific scrutiny, according to Dr. Brad Stanfield's analysis of recent research. The story began promisingly in the late 1990s when MIT researchers discovered that calorie restriction's longevity benefits in yeast required activation of the SIR2 protein, which depends on NAD. Subsequent studies showed NAD levels decline with age in humans, correlating with increased DNA damage and reduced cellular repair capacity.

Early mouse studies in 2016 seemed to confirm the theory, showing that NR supplements could restore youthful cellular function and extend lifespan. This sparked massive interest and celebrity endorsements, including David Sinclair's public advocacy for NMN supplements on Joe Rogan's podcast in 2019, despite no human clinical trials existing at the time.

However, the more rigorous Interventions Testing Program later tested NR in mice across three independent labs and found no lifespan extension despite confirmed increases in blood NAD levels. Human studies have consistently replicated this pattern - NAD precursors reliably raise blood levels but provide zero functional benefits. A recent long COVID study exemplified this disconnect, showing NR supplements increased NAD levels but failed to improve any symptoms despite the theoretical rationale.

The fundamental premise has also been challenged, with research showing that physically active older adults maintain NAD levels similar to younger people. People reporting benefits from NMN or NR may actually be experiencing effects from TMG supplements commonly taken alongside them, which have proven benefits for muscle performance and testosterone levels. The evidence suggests NAD precursor supplements represent expensive placebos rather than genuine anti-aging interventions.